GPT-6 Astra pilots a surveillance drone and runs a business on its own
GPT-6 Astra outperforms Claude Fable 5.1 on Vending-Bench and becomes the first model to beat the human-AI baseline on all five Drone-Bench subtasks.
Andon Labs tested OpenAI's GPT-6 Astra on two agent benchmarks: Vending-Bench 2, where Astra averaged $15,515 running a simulated vending-machine business versus Claude Fable 5.1's $5,422, and Drone-Bench, where models write code for a DJI Tello EDU drone to navigate an office and follow a specific person. Astra is the first model whose best submissions beat the human-AI baseline on all five Drone-Bench subtasks, using a COLMAP and DA3 pipeline with depth filtering for 3D reconstruction. Reliability remains limited, as an average Astra run has only a 2.8 percent chance of passing all five drone steps sequentially. In Vending-Bench Arena, Astra refused a price-fixing proposal from GLM-5.3, while Claude Fable 5.1 participated in an arrangement Andon Labs classified as illegal price-fixing.
Why don't machine learning research agents overfit?
Amazon researchers explain why ML research agents avoid benchmark overfitting, attributing generalization to compressibility of successful strategies.
Amazon Science summarizes the paper "What fits (into few tokens) doesn't overfit: Compression and generalization in ML research agents," which investigates why benchmark hill-climbing loops, whether run by human communities or LLM research agents, do not produce rampant overfitting. The explanation formalizes Occam's razor via a counting argument: successful ML strategies are highly compressible, so short descriptions lack room to memorize benchmark data and must capture real structure. LLM-based agents, being resettable and controllable, allow this hypothesis to be tested empirically.
Google DeepMind Releases AlphaGenome Atlas With Precomputed Molecular Effect Predictions and AVI Scores for 9 Billion Human DNA Variants
Google DeepMind launched AlphaGenome Atlas, precomputing molecular effect predictions and AVI impact scores for ~9 billion human single-nucleotide variants in a 1-petabyte catalogue.
Google DeepMind released AlphaGenome Atlas, a 1-petabyte catalogue of precomputed molecular effect predictions for roughly 9 billion possible single-nucleotide variants in the human genome. It introduces the AlphaGenome Variant Impact (AVI) score, combining AlphaGenome regulatory predictions with AlphaMissense, plus per-variant feature attributions and over 2,500 recurrent DNA sequence motifs. DeepMind reports best-in-class AVI performance on variant pathogenicity and rare disease benchmarks. Early users at the Broad Institute, University of Exeter, and Stowers Institute demonstrated rare-disease variant reprioritization and 22% more non-coding associations across 54,000+ UK Biobank genomes.
Google's AI genome system evaluates every possible one-base change
Google's AlphaGenome AI system predicts functional effects of non-coding DNA variants in humans and mice.
Google's AlphaGenome AI system evaluates genomic sequences to predict gene expression, transcription factor binding, chromatin accessibility, splice site usage, and related genomic features. The system is currently limited to human and mouse sequences and a limited set of well-studied cell types, but its predictions generally match or exceed specialized software tools. Researchers can use it to assess whether non-coding variants are likely significant and generate hypotheses about their function.